5-hydroxytryptamine metabolism in the brain under the influence of psychotropic drugs.
D000661:Amphetamine / Q000494:pharmacology; D000662:Amphetamines / Q000494:pharmacology; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D010134:Fenclonine / Q000494:pharmacology; D006213:Hallucinogens / Q000494:pharmacology; D006801:Humans; D008094:Lithium / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009410:Nerve Degeneration / Q000187:drug effects; D009474:Neurons / Q000502:physiology; D011619:Psychotropic Drugs / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism* / Q000502:physiology; D014149:Tranquilizing Agents / Q000494:pharmacology
D000662:Amphetamines; D000929:Antidepressive Agents, Tricyclic; D006213:Hallucinogens; D008996:Monoamine Oxidase Inhibitors; D011619:Psychotropic Drugs; D014149:Tranquilizing Agents; D012701:Serotonin; D008094:Lithium; D000661:Amphetamine; D010134:Fenclonine